Comparison of 18- and 22-MHz probes for the ultrasonographic diagnosis of giant cell arteritis.
giant cell arteritis
high frequency probes
ultrasound
Journal
Journal of clinical ultrasound : JCU
ISSN: 1097-0096
Titre abrégé: J Clin Ultrasound
Pays: United States
ID NLM: 0401663
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
revised:
14
01
2021
received:
04
11
2020
accepted:
23
01
2021
pubmed:
12
2
2021
medline:
17
6
2021
entrez:
11
2
2021
Statut:
ppublish
Résumé
Little is known about the diagnostic concordance of images provided by ultrasound probes with emitting frequencies below or above 20 MHz for the diagnosis of giant cell arteritis (GCA). We compared, using Cohen's kappa statistic, data obtained with an 18-MHz and a 22-MHz probe for the ultrasonographic evaluation of temporal arteries in 80 patients referred for suspected GCA. The halo sign was found in 25% of cases with the 18-MHz probe and in 35% with the 22-MHz probe. The compression sign was positive in 42% of cases with the 18-MHz probe and 48% with the 22-MHz probe. GCA was finally diagnosed in 20 patients (25%). The kappa coefficient of agreement was 0.76 (P < .001) for the halo sign, and 0.75 (P < .001) for the compression sign. Images obtained by 18 MHz and 22-MHz frequency probes showed a good level of agreement for the diagnosis of GCA, but the 22-MHz probe yielded a correct diagnosis of GCA in 3 of the 7 patients in whom examination with the 18-MHz probe was negative.
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
546-553Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Koster MJ, Warrington KJ. Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets. BMC Rheumatol. 2017;1:2.
Kermani TA, Diab S, Sreih AG, et al. Arterial lesions in giant cell arteritis: a longitudinal study. Semin Arthritis Rheum. 2019;48:707-713.
Ninan JV, Lester S, Hill CL. Giant cell arteritis: beyond temporal artery biopsy and steroids. Intern Med J. 2017;47:1228-1240.
Winkler A, True D. Giant cell arteritis: 2018 review. Mol Med. 2018;115:468.
Sait MR, Lepore M, Kwasnicki R, et al. The 2016 revised ACR criteria for diagnosis of giant cell arteritis - our case series: can this avoid unnecessary temporal artery biopsies? Int J Surg Open. 2017;9:19-23.
Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122.
Baig IF, Pascoe AR, Kini A, Lee AG. Giant cell arteritis: early diagnosis is key. Eye Brain. 2019;11:1-12.
Luqmani R, Lee E, Singh S, et al. The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess. 2016;20:1-238.
Schmidt WA. Ultrasound in the diagnosis and management of giant cell arteritis. Rheumatology. 2018;57(2):22.
Aschwanden M, Daikeler T, Kesten F, et al. Temporal artery compression sign-a novel ultrasound finding for the diagnosis of giant cell arteritis. Ultraschall Med. 2013;34:47.
Begarin L, Dumesnil A, Assie-Chauvier C, Benhamou Y, Cailleux-Talbot N, Levesque H. Performance diagnostique d'un nouveau critère échographique dans la maladie de Horton: épaisseur intima media temporale/épaisseur intima media carotidienne. J Mal Vasc. 2013;38:311-312.
Monti S, Floris A, Ponte C, et al. The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist. Rheumatology. 2018;57:227-235.
Duftner C, Dejaco C, Sepriano A, Falzon L, Schmidt WA, Ramiro S. Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations. RMD Open. 2018;4:e000612.
Aschwanden M, Imfeld S, Staub D, et al. The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement. Clin Exp Rheumatol. 2015;33(2):113.
Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636-643.
Ehlers L, Askling J, Bijlsma HW, et al. 2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis. Ann Rheum Dis. 2019;78:1160.
Chrysidis S, Duftner C, Dejaco C, et al. Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT large vessel vasculitis ultrasound working group. RMD Open. 2018;4:e000598.
Davies C, May D. The role of temporal artery biopsies in giant cell arteritis. Ann R Coll Surg Engl. 2011;93:4-5.
Romera-Villegas A, Vila-Coll R, Poca-Dias V, Cairols-Castellote MA. The role of color duplex sonography in the diagnosis of giant cell arteritis. J Ultrasound Med. 2004;23:1493-1498.
Maldini C, Dépinay-Dhellemmes C, Tra TTS, et al. Limited value of temporal artery ultrasonography examinations for diagnosis of giant cell arteritis: analysis of 77 subjects. J Rheumatol. 2010;37:2326-2330.
Monti S, Floris A, Ponte CB, et al. The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice. Rheumatology. 2018;57:112-119.
Nesher G, Shemesh D, Mates M, et al. The predictive value of the halo sign in color Doppler ultrasonography of the temporal arteries for diagnosing giant cell arteritis. J Rheumatol. 2002;29:1224.
Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JPA. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005;142:359-369.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
Fernández-Fernández E, Monjo-Henry I, Bonilla G, et al. False positives in the ultrasound diagnosis of giant cell arteritis: some diseases can also show the halo sign. Rheumatology. 2020;59:2443-2447.